Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Open-label Multi-centre Comparative Study to Evaluate Cycle Control of 2 Dosages of Estetrol Combined With Either P1 or P2, Compared to a Combined Oral Contraceptive Containing E2V and DNG

NCT01221831 is registered in ClinicalTrials.gov with Estetra as lead sponsor.

NCT NCT01221831
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01221831 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Open-label Multi-centre Comparative Study to Evaluate Cycle Control of 2 Dosages of Estetrol Combined With Either P1 or P2, Compared to a Combined Oral Contraceptive Containing E2V and DNG
Lead sponsor
Estetra
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2010
Completion date
September 30, 2011
Enrollment
396 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

contraception